Status:

COMPLETED

Effect of IV Iron Isomaltoside on Postoperative Anemia in Total Knee Arthroplasty Patients

Lead Sponsor:

Seoul National University Hospital

Conditions:

Anemia

Knee Arthropathy

Eligibility:

All Genders

19+ years

Phase:

NA

Brief Summary

Postoperative anemia is a frequent complication after total knee arthroplasty, with an incidence of 87%. Iron supplementation is known to be effective in treatment and prevention of postoperative anem...

Eligibility Criteria

Inclusion

  • Adult patients undergoing total knee arthroplasty

Exclusion

  • bilateral total knee arthroplasty
  • hematochromatosis or hemosiderosis
  • hemolytic anemia
  • history of drug allergy
  • liver cirrhosis or hepatitis
  • systematic lupus erythematosus
  • rheumatic arthritis
  • allergic disease
  • history of transfusion within one month from surgery
  • parturient

Key Trial Info

Start Date :

March 29 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 17 2019

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT03470649

Start Date

March 29 2018

End Date

April 17 2019

Last Update

April 18 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Seoul National University Hospital

Seoul, South Korea, 03080

Effect of IV Iron Isomaltoside on Postoperative Anemia in Total Knee Arthroplasty Patients | DecenTrialz